ImmuCell Corporation AMENDMENT TO RIGHTS AGREEMENTRights Agreement • November 21st, 2022 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances
THIS AMENDMENT is entered into as of August 10, 2022, between IMMUCELL CORPORATION, a Delaware corporation (the “Company”), and American Stock Transfer & Trust Co., a New York corporation, as Rights Agent (the “Rights Agent”).
